Clinical Trial Update: Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating propranolol with standard radiation therapy before surgery for soft tissue sarcoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Soft Tissue Sarcoma | Phase 1 | Status: WITHDRAWN